Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
NCT00506701
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
due to lack of finance
Conditions
Chronic Obstructive Lung Disease
Interventions
DRUG:
Tadalafil
Sponsor
Herlev Hospital